{"schema_version":"1","generated_at":"2026-10-30T15:32:18.866Z","data_as_of":null,"url":"https://www.findmykol.com/kol/molly-warthan","json_url":"https://www.findmykol.com/kol/molly-warthan/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"molly-warthan","name":"Molly Warthan","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"Eastern Virginia Medical School","institution_url":"https://www.findmykol.com/institution/eastern-virginia-medical-school","city":"Fort Worth","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1073773867","openalex":"A5000050671"},"summary":"Molly Warthan is a Dermatology physician affiliated with Eastern Virginia Medical School. OpenAlex indexes 14 publications with 312 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":14,"cited_by_count":312,"h_index":7,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":27,"program_years":{"first":2021,"last":null},"rows_total":65,"shown":3,"withheld":62,"rows":[{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":186.37,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1073773867"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":157.51,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1073773867"},{"payer":"REVANCE THERAPEUTICS, INC.","program_year":2025,"amount_usd":89.26,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1073773867"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1073773867","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":60.5,"classes_total":2,"classes":[{"class":"Porphyrin Precursor","setting":"administered","share_pct":60.2,"drugs":[{"name":"Aminolevulinic acid hcl","share_pct":100}],"max_beneficiaries":14},{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":0.3,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":21.9,"classes_total":4,"classes":[{"class":"First-generation cephalosporins","setting":"prescribed","share_pct":19.8,"drugs":[{"name":"Cephalexin","share_pct":100}],"max_beneficiaries":708},{"class":"Tetracycline-class Drug","setting":"prescribed","share_pct":1.4,"drugs":[{"name":"Doxycycline Hyclate","share_pct":73.5},{"name":"Doxycycline Monohydrate","share_pct":26.5}],"max_beneficiaries":41}]},{"area":"Nervous system","share_pct":12.7,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":12.7,"drugs":[{"name":"Tramadol Hcl","share_pct":100}],"max_beneficiaries":523}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"OpenAlex author record","recent":[{"title":"Scurvy in a 10‐Year‐Old Boy","year":2010,"journal":"Pediatric Dermatology","source_url":"https://doi.org/10.1111/j.1525-1470.2010.01095.x","status":"verified"},{"title":"Two Reports of Phacomatosis Pigmentovascularis Type Iib, One in Association with Sturge-Weber Syndrome and Klippel-Trenaunay Syndrome","year":2010,"journal":"Pediatric Dermatology","source_url":"https://doi.org/10.1111/j.1525-1470.2010.01144.x","status":"verified"},{"title":"Mondor Disease in a Patient With Psoriasis Treated With an Anti–Interleukin 12/Interleukin 23 Investigational Drug","year":2010,"journal":"Archives of Dermatology","source_url":"https://doi.org/10.1001/archdermatol.2010.232","status":"verified"},{"title":"Acquired acrodermatitis enteropathica secondary to alcoholism.","year":2008,"journal":"PubMed","status":"verified"},{"title":"Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors.","year":2008,"journal":"PubMed","status":"verified"}],"source":"works"},"contact":{"address_1":"5751 EDWARDS RANCH RD STE 101","city":"Fort Worth","state":"TX","zip":"761094131","phone":"817-923-8220","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1073773867","source":"identity"},"similar":[{"name":"David Pariser","slug":"david-pariser","institution":"Eastern Virginia Medical School","specialty":"Dermatology","url":"https://www.findmykol.com/kol/david-pariser","json_url":"https://www.findmykol.com/kol/david-pariser/profile.json"},{"name":"Craig Derkay","slug":"craig-derkay","institution":"Eastern Virginia Medical School","specialty":"Otolaryngology","url":"https://www.findmykol.com/kol/craig-derkay","json_url":"https://www.findmykol.com/kol/craig-derkay/profile.json"},{"name":"Peter Netland","slug":"peter-netland","institution":"Eastern Virginia Medical School","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/peter-netland","json_url":"https://www.findmykol.com/kol/peter-netland/profile.json"},{"name":"Abby Van Voorhees","slug":"abby-van-voorhees","institution":"Eastern Virginia Medical School","specialty":"Dermatology","url":"https://www.findmykol.com/kol/abby-van-voorhees","json_url":"https://www.findmykol.com/kol/abby-van-voorhees/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Victoria Werth","slug":"victoria-werth","institution":"Perelman School of Medicine at the University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/victoria-werth","json_url":"https://www.findmykol.com/kol/victoria-werth/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":62,"publications":8}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-09-23","provider_certified":"2020-09-23","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}